Trial Condition(s):

Hypertension

Assessment of Compliance With Antihypertensive Telmisartan Therapy (COAST)

Bayer Identifier:

12827

ClinicalTrials.gov Identifier:

NCT00470886

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.

Inclusion Criteria
- Age over 18
 - Untreated or ineffectively treated arterial hypertension
Exclusion Criteria
- Cholestatic disorders and severe hepatic failure
 - Allergy to Telmisartan
 - Pregnancy and lactation period
 - Unwillingness to participate in the study
 - Inability to use the drug reminder device
 - Unwillingness to use the drug reminder device

Trial Summary

Enrollment Goal
3400
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Poland

Status
Completed
 
Locations

Investigative Site

Many Locations, Slovakia

Status
Completed
 

Trial Design